2017
NanoSUR's Foundation.
Team
Darren Wakefield
Director of Chemistry
- +16 Years of experience in the Chemical modification, bioconjugation and delivery of nucleic acids
- Roche
- MirusBio
- Co-inventor in 50 US patents
Graciela Arhancet
President
- Director Innovation – Novus International (2010 -2017)
- Leadership in Drug Discovery and Early
- Development – Pfizer (1999-2020)
- She is the autor and holder of more than fifty publications and patents
Juan Arhancet
CEO
- CEO and founder of Apse Inc.
(2010 -2016) - Associate Fellow – Monsanto
(1999-2010) - Research Engineer – Shell
(1991 -1999) - 45 granted US patents, and 9 publicantions
Andrew Fehretdinov
CFO
- 15 Years of Financial management and accounting experience
- CFO – Incentive Technology Group (2016-2020)
- VP of Finance – Digital Management (2009 – 2014)
Vladimir Trubetskoy
Director of Formulation
- Principal Scientist – Arrowhead Pharmaceuticals
(2011-2016) - Principal Scientist – Roche
(2008-2011) - Senior Scientist – Mirus Bio
(2006-2008) - He is co-author of 38 original researchs papers, 9 reviews/book chapter and co-inventor on 33 US patents
Our History
2018
- Start of phase I NSF-funded Project on new RNAi triggers.
- First patent on RNAi triggers granted.
2019
- Start of phase II NSF-funded Project on DBM control.
- Start of phase I USDA-funded Project on RIFA control.
2020
- Scalable methods of manufacture developed.
- Additional composition of matter manuf.
- Patents filed.
2021
Start of phase I II USDA-funded projects
(gypsy moth RIFA).
2022
- Successful FIELD TRIALS in FL CA protecting two vegetables from a major pest (DBM).
- Additional Patents filed on manuf. of MdsRNA.
2023
Start of phase II USDA-funded project
(gypsy moth).
Logo Evolution
Inspiration
Growth
Success